One-Shot gene therapy aims to permanently lower bad cholesterol
NCT ID NCT06164730
Summary
This early-stage study is testing the safety of a single dose of an experimental gene-editing treatment called VERVE-102. It is designed for people with inherited high cholesterol or early heart disease who need to lower their 'bad' LDL cholesterol further. The treatment aims to permanently edit a gene in the liver to reduce cholesterol levels, potentially offering long-term control without daily medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREMATURE CORONARY HEART DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Study Center
RECRUITINGDothan, Alabama, 36305, United States
-
Clinical Study Center
RECRUITINGPomona, California, 91768, United States
-
Clinical Study Center
RECRUITINGBoca Raton, Florida, 33434, United States
-
Clinical Study Center
RECRUITINGWinter Park, Florida, 32789, United States
-
Clinical Study Center
RECRUITINGHigh Point, North Carolina, 27260, United States
-
Clinical Study Center
RECRUITINGDeSoto, Texas, 75115, United States
-
Clinical Study Center
RECRUITINGRenton, Washington, 98057, United States
-
Clinical Study Center
RECRUITINGAdelaide, Australia
-
Clinical Study Center
RECRUITINGMelbourne, Australia
-
Clinical Study Center
ACTIVE_NOT_RECRUITINGSydney, Australia
-
Clinical Study Center
RECRUITINGChicoutimi, Canada
-
Clinical Study Center
RECRUITINGMontreal, Canada
-
Clinical Study Center
RECRUITINGToronto, Canada
-
Clinical Study Center
RECRUITINGVancouver, Canada
-
Clinical Study Center
RECRUITINGRehovot, Israel
-
Clinical Study Center
RECRUITINGChristchurch, New Zealand
-
Clinical Study Center
RECRUITINGBirmingham, United Kingdom
-
Clinical Study Center
RECRUITINGEdinburgh, United Kingdom
-
Clinical Study Center
RECRUITINGLondon, United Kingdom
-
Clinical Study Center
RECRUITINGManchester, United Kingdom
-
Clinical Study Center
RECRUITINGNottingham, United Kingdom
Conditions
Explore the condition pages connected to this study.